Scientists test 'Bacterial Bomb' to blast open tough tumors
NCT ID NCT03435952
Summary
This early-stage study is testing a new combination treatment for advanced solid tumors that have stopped responding to standard therapies. Researchers are injecting a modified, non-toxic bacteria directly into a tumor to help break it down, while also giving an immunotherapy drug (pembrolizumab) to boost the body's own immune attack. The main goals are to find a safe dose and see if this approach can help control the cancer in up to 18 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM OF BREAST are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.